The chronic inflammation observed in IBD patients is thought to be responsible for the increase in PWV, thus affecting arterial stiffening, and prompting some researchers to use PWV as a way of measuring the efficacy of anti-TNF-alpha medications in reversing arterial wall stiffening [9]. Here, TNF is linked to inflammatory bowel disease.